Improved humoral and cellular immune responses against the gp120 V3 loop of HIV-1 following genetic immunization with a chimeric DNA vaccine encoding the V3 inserted into the hepatitis B surface antigen

Scandinavian Journal of Immunology

Volumn 47, Issue 4, 1998, Pages 289-295

  Fomsgaard, A ^a   Nielsen, H V ^a   Bryder, K ^a   Nielsen, C ^a   Machuca, R ^a   Bruun, L ^a   Hansen, J ^b   Buus, S ^c  

^a STATENS SERUM INSTITUT   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; EPITOPE; GLYCOPROTEIN GP 120; HEPATITIS B SURFACE ANTIGEN;

ANIMAL EXPERIMENT; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HEPATITIS B VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOGENICITY; INFECTION RESISTANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINE PRODUCTION;

AIDS VACCINES; AMINO ACID SEQUENCE; ANIMALS; FEMALE; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP120; HUMANS; IMMUNIZATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; MUTAGENESIS, INSERTIONAL; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, DNA;

EID: 0031979153     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1998.00323.x     Document Type: Article

References (28)

1. Haigwood NL, Watson A, Sutton WF et al. Passive immunoglobulin therapy in the SIV macaque model: early intervention can alter disease profile. Immunol Lett 1996;51:107-14.
2. Prince AM, Reesink H, Pascual D et al. Prevention of HIV infection by passive immunization with HIV immunoglobulin. AIDS Res Hum Retroviruses 1991;7:971-3.
3. Moore JP. Back to primary school. Nature 1995;376:115.
4. Borrow PH, Lewicki X, Wei MS et al. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTSs) during primary infection demonstrated by rapid selection of CTL escape virus. Nature Med 1997;3:205-11.
5. McMichael AJ, Philips RE. Escape of human immunodeficiency virus from immune control. Annu Rev Immunol 1997;15:271-96.
6. Pinto LA, Sullivan J, Berzofsky JA et al. Env-specific cytotoxic T lymphocytes responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids. J Clin Invest 1995;96:867-76.
7. Rowland-Jones SJ, Sutton K, Ariyoshi T et al. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nature Med 1995;1:59-64.
8. Zagury D. A naturally unbalanced combat. Nature Med 1997;3:156-7.
9. Donnelly JJ, Ulmer JB, Liu M. DNA vaccines. Life Science 1997;60:163-72.
10. Wharen B. Gene vaccines. Immunotechnology 1996;2:77-83.
11. Ulmer JB, Deck RR, Dewitt CM, Donnelly JJ, Liu MA. Generation of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non-muscle cells. Immunology 1996;89:59-67.
12. Boyer JD, Ugen KE, Wang B et al. Protection of chimpanzees from high-close heterologous HIV-1 challenge by DNA vaccination. Nature Med 1997;3:526-32.
13. Boyer JD, Wang B, Ugen KE et al. In vivo protective anti-HIV immune responses in non-human primates through DNA immunization. J Med Primatol 1996;25:242-50.
14. Mancini M, Davis H, Tiollais P, Michel M-L. DNA-based immunization against the envelope proteins of the hepatitis B virus. J Biothechnol 1996;44:47-57.
15. Wang B, Ugen KE, Srikantan V et al. Gene inoculation generates immune responses against human immunodeficiency virus type-1. Proc Natl Acad Sci USA 1993;90:4156-60.
16. Davis HL, Michel M-L, Whalen RG. DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. Hum Mol Genet 1993;2:1847-51.
17. Delpeyroux F, Chenciner N, Lim A et al. A poliovirus neutralization epitope expressed on hybrid hepatitis B surface antigen particles. Science 1986;233:472-5.
18. Michel M-L, Mancini M, Sobczak E et al. Induction of anti-human immunodeficiency virus (HIV) neutralizing antibodies in rabbits immunized with recombinant HIV-hepatitis B surface antigen particles. Proc Natl Acad Sci USA 1988;85:7957-61.
19. Major ME, Vitvitski L, Mink MA et al. DNA-based immunization with chimeric vectors for the induction of immune responses against the hepatitis C virus nucleocapsid. J Virol 1995;69:5798-805.
20. Valenzuela P, Medina A, Rutter WJ, Ammerer G, Hall BD. 1982. Synthesis and assembly of hepatitis B virus surface antigen particles in yeast. Nature 1982;298:347-50.
21. Michel M-L, Pontisso P, Sobczak E, Malpièce Y, Streeck RE, Tiollais P. Synthesis in animal cells of hepatitis B surface antigen particles carrying a receptor for polymerized human serum albumin. Proc Natl Acad Sci USA 1994;81:7708-12.
22. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory Press, 1989.
23. Takahashi H, Merli S, Putney SD et al. A single amino acid interchange yields reciprocal CTL specificities for HIV-1 gp160. Science 1989;246:118-21.
24. Pertmer TM, Eisenbaum MD, McCabe D, Prayaga SK, Fuller DH, Haynes JR. Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA. Vaccine 1995; 13:1427-30.
25. Marker O, Volkert, M. Studies on cell-mediated immunity to lymphocytic chorionmeningitis virus in mice. J Exp Med 1973; 137:1511-13.
26. Milich DR. T- and B-cell recognition of hepatitis B viral antigens. Immunol Today 1988;9:380-6.
27. Milich DR, McLachlan A, Chisari FV, Thornton GB. Non-overlapping T and B cell determinants on an hepatitis B surface antigen pre-S[2] region synthetic peptide. J Exp Med 1986;164:532-47.
28. Fomsgaard A, Nielsen HV, Nielsen C et al. Comparisons of DNA mediated immunization procedures to surface glycoproteins of human immunodeficiency virus type-1 and hepatitis B virus. APMIS. in press.